Nektar up on Exubera vote

NKTR rose $0.45 to $19.59 on 18.3 million shares following Thursday's FDA panel vote in favor of approval of Exubera inhaled insulin powder from Pfizer (PFE) and sanofi-aventis (Euronext:SAN; SNY) to ...